GENAISSANCE PHARMACEUTICALS INC
S-1/A, EX-23.1, 2000-07-28
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: GENAISSANCE PHARMACEUTICALS INC, S-1/A, EX-10.35, 2000-07-28
Next: EROOM SYSTEM TECHNOLOGIES INC, SB-2/A, 2000-07-28



<PAGE>

                                                              EXHIBIT 23.1


                           [ARTHUR ANDERSEN LETTERHEAD]


CONSENT OF INDEPENDENT PUBLIC ACCOUNTANTS


To the Board of Directors and Shareholders of
Genaissance Pharmaceuticals, Inc.:


As independent public accountants, we hereby consent to the use of our report
dated March 10, 2000 (and to all references to our Firm) included in or made
a part of this registration statement.

                                            /s/ ARTHUR ANDERSEN LLP

Hartford, Connecticut
July 28, 2000


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission